Medicure Inc. Signs New Agreement, Files 6-K
Ticker: MCUJF · Form: 6-K · Filed: Jun 25, 2024 · CIK: 1133519
| Field | Detail |
|---|---|
| Company | Medicure Inc (MCUJF) |
| Form Type | 6-K |
| Filed Date | Jun 25, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing, agreement, regulatory
TL;DR
Medicure Inc. signed a new deal and filed a 6-K, confirming they'll use Form 20-F for annual reports.
AI Summary
On June 24, 2024, Medicure Inc. announced the signing of a new agreement. The company, headquartered at 2-1250 Waverley Street in Winnipeg, MB Canada, filed a Form 6-K report with the SEC. The filing indicates that Medicure Inc. will be filing its annual reports under Form 20-F.
Why It Matters
This filing signals ongoing business activities and regulatory compliance for Medicure Inc., providing an update to investors on their corporate actions.
Risk Assessment
Risk Level: low — This is a routine filing announcing a new agreement and confirming reporting procedures, with no immediate financial or operational risks disclosed.
Key Players & Entities
- Medicure Inc. (company) — Registrant
- Dr. Albert D. Friesen (person) — CEO
- June 24, 2024 (date) — Filing Date
- 20240624 (date) — Report Period Date
FAQ
What type of agreement did Medicure Inc. announce?
The filing announces the signing of a new agreement, but the specific details of the agreement are not provided in this Form 6-K.
What is Medicure Inc.'s principal executive office address?
Medicure Inc.'s principal executive offices are located at 2-1250 Waverley Street, Winnipeg, MB Canada R3T 6C6.
Which form will Medicure Inc. use for its annual reports?
Medicure Inc. will file its annual reports under cover of Form 20-F.
Who signed the Form 6-K on behalf of Medicure Inc.?
Dr. Albert D. Friesen, CEO, signed the Form 6-K on behalf of Medicure Inc.
What is the Commission File Number for Medicure Inc.?
The Commission File Number for Medicure Inc. is 001-31995.
Filing Stats: 145 words · 1 min read · ~1 pages · Grade level 8.1 · Accepted 2024-06-24 17:36:23
Filing Documents
- med_6k.htm (6-K) — 10KB
- med_ex991.htm (EX-99.1) — 19KB
- med_ex991img2.jpg (GRAPHIC) — 3KB
- 0001654954-24-008111.txt ( ) — 34KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Medicure Inc. (Registrant) Date: June 24, 2024 By: /s/ Dr. Albert D. Friesen Dr. Albert D. Friesen Title: CEO 3